The global prefilled syringe drug molecule market is poised for substantial growth, with sales projected to increase from USD 70.2 billion in 2024 to an impressive USD 125.7 billion by 2034, reflecting a CAGR of 6% during the forecast period. This surge is driven by increasing adoption of self-administration, rising demand for biological drugs, and …